A quantitative DOPA decarboxylase biomarker for diagnosis in Lewy body disorders. Bolsewig K, Bellomo G, Hok-A-Hin YS, Al Idrissi I, et al. Nat Med 2026;32:1073-1084.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bolsewig K, Bellomo G, Hok-A-Hin YS, Al Idrissi I, et al. A quantitative DOPA decarboxylase biomarker for diagnosis in Lewy body disorders. Nat Med 2026;32:1073-1084.
PMID: 41699128